Quantum computational analysis for drug resistance of HIV-1 reverse transcriptase to nevirapine through point mutations

被引:50
作者
He, X
Mei, Y
Xiang, Y
Zhang, DW
Zhang, JZH [1 ]
机构
[1] NYU, Dept Chem, New York, NY 10003 USA
[2] Nanjing Univ, Dept Chem, Inst Theoret & Computat Chem, Key Lab Mesoscop Chem,Minist Educ, Nanjing 210093, Peoples R China
关键词
D O I
10.1002/prot.20578
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quantum chemical calculation has been carried out to analyze binding interactions of nevirapine to HIV-1 reverse transcriptase (RT) and single point mutants Lys103 -> Asn (K103N) and Tyr181 -> Cys (Y181C). In this study, the entire system of HIV-1 RT/nevirapine complex with over 15,000 atoms is explicitly treated by using a recently developed MFCC (molecular fractionation with conjugate caps) approach. Quantum calculation of protein-drug interaction energy is performed at Hartree-Fock and DFT levels. The RT-nevirapine interaction energies are computed at fixed geometries given by the crystal structures of the HIV-1 RT/nevirapine complexes from protein data bank (PDB). The present calculation provides a quantum mechanical interaction spectrum that explicitly shows interaction energies between nevirapine and individual amino-acid fragments of RT. Detailed interactions that are responsible for drug resistance of two major RT mutations are elucidated based on computational analysis in relation to the crystal structures of binding complexes. The present result provides a qualitative molecular understanding of HIV-1 RT drug resistance to nevirapine and gives useful guidance in designing improved inhibitors with better resistance to RT mutation.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 37 条
[1]   The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages [J].
Archer, RH ;
Wisniewski, M ;
Bambara, RA ;
Demeter, LM .
BIOCHEMISTRY, 2001, 40 (13) :4087-4095
[2]   Resistance to non-nucleoside inhibitors of HIV-I reverse transcriptase [J].
Bacheler, LT .
DRUG RESISTANCE UPDATES, 1999, 2 (01) :56-67
[3]   Fractionation of peptide with disulfide bond for quantum mechanical calculation of interaction energy with molecules [J].
Chen, XH ;
Zhang, DW ;
Zhang, JZH .
JOURNAL OF CHEMICAL PHYSICS, 2004, 120 (02) :839-844
[4]   Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors [J].
Corbett, JW ;
Ko, SS ;
Rodgers, JD ;
Gearhart, LA ;
Magnus, NA ;
Bacheler, LT ;
Diamond, S ;
Jeffrey, S ;
Klabe, RM ;
Cordova, BC ;
Garber, S ;
Logue, K ;
Trainor, GL ;
Anderson, PS ;
Erickson-Viitanen, SK .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (10) :2019-2030
[5]   New developments in anti-HIV chemotherapy [J].
De Clercq, E .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3) :258-275
[6]  
DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO
[7]  
2-2
[8]  
Jonckheere H, 2000, MED RES REV, V20, P129, DOI 10.1002/(SICI)1098-1128(200003)20:2<129::AID-MED2>3.0.CO
[9]  
2-A
[10]   THE RETROVIRAL ENZYMES [J].
KATZ, RA ;
SKALKA, AM .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :133-173